Direktorat Registrasi ObatValid

DEXTROSE MONOHYDRATE

Claim this product
BPOM Number
GKL1733315049B2
Approved
25 June 2026
Expiry
20 February 2030
Form
INFUS

About This Registration

DEXTROSE MONOHYDRATE is a BPOM-registered direktorat registrasi obat in Indonesia, registered under number GKL1733315049B2. Its current registration status is Valid, with the licence valid until 20 February 2030. The product is registered to MERSIFARMA TIRMAKU MERCUSANA and manufactured by MERSIFARMA TIRMAKU MERCUSANA - INDONESIA. BPOM first approved this registration in May 2026. All registration data is sourced directly from the official BPOM public database and updated daily.

Registration data updated by BPOM

This product's registration details were changed on 3 July 2026. This may reflect a status change, renewal, or correction by BPOM.

Registration Details

Application
newaero
Packaging
BOTOL PLASTIK @ 500 ML
Department
Direktorat Registrasi Obat
Data Last Updated
3 July 2026

Retail Audit Service

Get detailed market intelligence for this product across Indonesian retail channels

Multiple cities available
Custom questionnaires
Professional shoppers
Detailed reporting
Starting from $50 per city
What's included in the audit service?

Stock availability and positioning verification

Price checking and competitor analysis

Display quality and promotional material assessment

Store condition and customer experience evaluation

Custom questions tailored to your research needs

Professional photographs and detailed reports

Registered Owners

  • MERSIFARMA TIRMAKU MERCUSANA

    Kab. Sukabumi, Jawa Barat, Indonesia

    NPWP: 017924341441000

    owner
    View profile →

Ingredients (1)

DEXTROSE MONOHYDRATE

Market Intelligence

Owner Portfolio
MERSIFARMA TIRMAKU MERCUSANA holds 220 BPOM registrations
Manufacturer Scale
MERSIFARMA TIRMAKU MERCUSANA - INDONESIA produces 220 registered products
Registration Age
Registered for 4 months
Update Status
Recently updated (90 days ago)

FDA Cross-Reference

via openFDA
Generic Name
DEXTROSE MONOHYDRATE, SODIUM CITRATE, UNSPECIFIED FORM, AND CITRIC ACID MONOHYDRATE
Product Type
HUMAN PRESCRIPTION DRUG
Route of Administration
INTRAVENOUS

Data sourced from the U.S. FDA drug label database (openFDA). May not exactly match this product variant.

Is this your product?

Claim it to manage registration, track renewals, and get expiry alerts.

Claim Product
1